Guardant Health, Inc. (NAS: GH) Stock Analysis & Fundamentals | ScreenerHero

Create free account

GHGuardant Health, Inc.

NAS · US · Healthcare · Diagnostics & Research · guardanthealth.com

150.03USD-2.41%Mkt Cap: 19.89B $P/E: —1d ago

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company offers Guardant360 CDx test, a liquid biopsy test for tumor mutati…

Industry Peers

Diagnostics & Research

vs Diagnostics & Research

1M Perf

Lower

Thermo Fisher Scientific Inc.

$186.32BUSDP/E 27.6

Danaher Corporation

$134.82BUSDP/E 36.8

$43.51BUSDP/E 42.0

IDEXX Laboratories, Inc.

$41.53BUSDP/E 38.7

Agilent Technologies, Inc.

$37.53BUSDP/E 26.7

Waters Corporation

$36.82BUSDP/E 47.7

IQVIA Holdings Inc.

$32.25BUSDP/E 24.0

$26.60BUSDP/E 31.9

Mettler-Toledo International Inc.

$25.82BUSDP/E 30.0

Quest Diagnostics Incorporated

$23.46BUSDP/E 23.4

Labcorp Holdings Inc.

$22.96BUSDP/E 24.8

Medpace Holdings, Inc.

$15.12BUSDP/E 33.3

Eurofins Scientific SE

$12.91BUSDP/E 26.9

$12.41BUSDP/E 53.5

Charles River Laboratories International, Inc.

bioMérieux S.A.

$8.81BUSDP/E 20.6

Twist Bioscience Corporation

BillionToOne, Inc.

$5.52BUSDP/E 222.2

Sotera Health Company

$5.06BUSDP/E 43.3

$4.69BUSDP/E 54.4

DiaSorin S.p.A.

$3.65BUSDP/E 25.7

Adaptive Biotechnologies Corporation

GeneDx Holdings Corp.

NeoGenomics, Inc.

Vimian Group AB (publ)

$1.48BUSDP/E 37.4

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Personalis, Inc.

OPKO Health, Inc.

Clínica Baviera, S.A.

$1.01BUSDP/E 21.1

Castle Biosciences, Inc.

$615.20MUSDP/E 40.1

Fulgent Genetics, Inc.

Myriad Genetics, Inc.

$297.38MUSDP/E 3.0

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Eurofins-Cerep SA

$94.30MUSDP/E 18.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

$10.07MUSDP/E 63.2

ENDRA Life Sciences Inc.

Proteome Sciences plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Oxford BioDynamics Plc

Leveljump Healthcare Corp.

$3.86MUSDP/E 2.8

Telo Genomics Corp.

Prostatype Genomics AB (publ)

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap19.89B $

Enterprise Value20.50B $

Revenue (TTM)1.08B $

Gross Profit633.01M $

Net Income (TTM)-416.28M $

Revenue/Share8.491 USD

Last Price150.03 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees2.5K

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISINUS40131M1099

Valuation

P/E (Trailing)—

P/E (Forward)-382.88

PEG—

EV/EBITDA-50.22

EV/Revenue18.97

P/S18.42

P/B-108.95

EPS (TTM)-3.40

EPS (Forward)-0.39

52W Range

40.3597% of range153.95

52W High153.95 USD

52W Low40.35 USD

Profitability

Gross Margin64.46%

Oper. Margin-40.23%

EBITDA Margin-37.79%

Profit Margin-42.39%

ROE419.18%

ROA-20.67%

Growth

Revenue Growth48.30%

Earnings Growth—

Cash Flow & Leverage

Operating CF-184.76M $

CapEx (TTM)48.31M $

FCF Margin-7.91%

FCF Yield-0.43%

Net Debt601.80M $

Net Debt/EBITDA-1.47

Balance Sheet

Debt/Equity-17.22

Current Ratio4.68

Quick Ratio4.25

Book Value/Sh-1.3770 USD

Cash/Share8.316 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.3 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)144.42 USD

Upside (mean)-3.7%

Target Range90.00 USD – 190.00 USD

$90.00-3.7% to mean$190.00

# Analysts24

Ownership

Shares Out.132.60M

Float127.89M

Insiders4.05%

Institutions108.58%

Short Interest

Short Ratio5.3d

Short % Float10.29%

Short % Out.9.87%

Shares Short13.09M

Short (prev mo.)12.93M

Technical

SMA 50112.55 (+33.3%)

SMA 20096.31 (+55.8%)

Beta1.62

S&P 52W Chg20.05%

Avg Vol (30d)2.62M

Avg Vol (10d)4.11M

Technical Indicators

RSI (14)72.5

MACD9.1165

MACD Signal7.9001

MACD Hist.+1.2164

BB Upper150.60 USD

BB Middle133.71 USD

BB Lower116.82 USD

BB Width25.27%

ATR (14)6.665 USD

Vol Ratio (20d)1.16x